| Analysis | Metabolite Name | Measured Value | Units | Source |
|---|---|---|---|---|
| GCMS positive ion mode | leucine | 1355.450237 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 1566.424323 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 1664.0625 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 1976.37051 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 2060.165975 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 2370.081411 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 2754.77707 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 3059.848005 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 3066.462168 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 3193.213296 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 3552.797203 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 3644.021739 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 3995.138369 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 3996.532594 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 4338.932214 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 4350.526316 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 4382.157124 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 4538.01593 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 4745.360825 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 4869.144981 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 5074.696212 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 5093.939394 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 5122.287968 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 5130.268199 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 5194.444444 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 5441.627752 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 5701.319095 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 5716.191067 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 5723.773585 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 5772.330423 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 5803.198433 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 5891.645729 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 6263.747454 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 6680.267559 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 6718.58217 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 7114.52514 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 7329.801777 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 7464.360587 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 7509.95355 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 8294.053662 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 8300.126103 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 8302.840909 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 8326.530612 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 8374.837451 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 8670.668954 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 8738.571429 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 8750.307125 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 8967.411546 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 9272.47191 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 9426.004228 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 10279.55272 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 10526.15063 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 11068.74621 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 11089.71554 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 11118.52378 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 11589.76021 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 11995.30957 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 12030.05636 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 12131.4628 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 12148.11321 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 12577.85235 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 12921.06959 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 13371.45819 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 13484.08957 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 13515.52795 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 13713.11971 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 14209.82143 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 14328.17754 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 14522.22222 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 14657.28477 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 14750.63694 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 14949.70986 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 14988.85135 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 15059.65909 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 15560.05491 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 15913.12867 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 16707.69231 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 17366.05982 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 17392.27642 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 17447.76876 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 17702.61219 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 18435.0741 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 18922.60274 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 18927.12551 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 19202.47934 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 20609.65473 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 21876.25755 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 22916.22517 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 23150.42373 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 23470.01934 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 24807.61387 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 25560.36217 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 25898.57143 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 28355.46875 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 28994.58362 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 29770.99237 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 30235.29412 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 32325 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | leucine | 32952.73312 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 37959.3687 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 38683.84615 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 38739.21085 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 56560.97561 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 58473 | Peak area | Method Blanks and BioRec Plasma - QC |
| GCMS positive ion mode | leucine | 58835.37832 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 59048 | Peak area | Method Blanks and BioRec Plasma - QC |
| GCMS positive ion mode | leucine | 59962 | Peak area | Method Blanks and BioRec Plasma - QC |
| GCMS positive ion mode | leucine | 64047 | Peak area | Method Blanks and BioRec Plasma - QC |
| GCMS positive ion mode | leucine | 67651 | Peak area | Method Blanks and BioRec Plasma - QC |
| GCMS positive ion mode | leucine | 89892 | Peak area | Method Blanks and BioRec Plasma - QC |
| GCMS positive ion mode | leucine | 147366.0969 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | leucine | 190293.7916 | Peak area | Group 2 - Visceral Fat |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|